Bradley Vaculin

609 total citations
10 papers, 429 citations indexed

About

Bradley Vaculin is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, Bradley Vaculin has authored 10 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Pharmacology. Recurrent topics in Bradley Vaculin's work include Drug Transport and Resistance Mechanisms (4 papers), Cannabis and Cannabinoid Research (3 papers) and Mast cells and histamine (2 papers). Bradley Vaculin is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Cannabis and Cannabinoid Research (3 papers) and Mast cells and histamine (2 papers). Bradley Vaculin collaborates with scholars based in United States, Italy and Japan. Bradley Vaculin's co-authors include Heather Francis, Sharon DeMorrow, Gianfranco Alpini, Julie Venter, Shannon Glaser, Shelley Vaculin, Eugenio Gaudio, Antonio Franchitto, Yoshiyuki Ueno and Paolo Onori and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Cancer Research.

In The Last Decade

Bradley Vaculin

10 papers receiving 424 citations

Peers

Bradley Vaculin
Shelley Vaculin United States
Yeo Kyoung Oh South Korea
Abraham D. Lee United States
E Liong Hong Kong
Shelley Vaculin United States
Bradley Vaculin
Citations per year, relative to Bradley Vaculin Bradley Vaculin (= 1×) peers Shelley Vaculin

Countries citing papers authored by Bradley Vaculin

Since Specialization
Citations

This map shows the geographic impact of Bradley Vaculin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bradley Vaculin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bradley Vaculin more than expected).

Fields of papers citing papers by Bradley Vaculin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bradley Vaculin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bradley Vaculin. The network helps show where Bradley Vaculin may publish in the future.

Co-authorship network of co-authors of Bradley Vaculin

This figure shows the co-authorship network connecting the top 25 collaborators of Bradley Vaculin. A scholar is included among the top collaborators of Bradley Vaculin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bradley Vaculin. Bradley Vaculin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Francis, Heather, Sharon DeMorrow, Julie Venter, et al.. (2008). The activation of H3/H4 histamine receptors induces a decrease in cholangiocarcinoma growth. Cancer Research. 68. 3602–3602. 1 indexed citations
2.
Francis, Heather, Shannon Glaser, Sharon DeMorrow, et al.. (2008). Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP 3 /CaMK I/CREB pathway. American Journal of Physiology-Cell Physiology. 295(2). C499–C513. 115 indexed citations
3.
DeMorrow, Sharon, Heather Francis, Eugenio Gaudio, et al.. (2008). The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway. American Journal of Physiology-Gastrointestinal and Liver Physiology. 295(6). G1150–G1158. 67 indexed citations
4.
Francis, Heather, Sharon DeMorrow, Julie Venter, et al.. (2008). 58 Evidence for a Novel Role for Histamine Regulation of Cholangiocarcinoma Growth By An Autocrine Mechanism. Gastroenterology. 134(4). A–753. 2 indexed citations
5.
Glaser, Shannon, Eugenio Gaudio, Heather Francis, et al.. (2008). S1590 Bile Acid Feeding Prevents Hepatic Artery Ligation-Induced Bile Duct Injury in Bile Duct Ligated Rats (BDL) By PI3K/AKT-Dependent Activation of Cholangiocyte VEGF-a Expression. Gastroenterology. 134(4). A–777. 1 indexed citations
6.
Taffetani, Silvia, Shannon Glaser, Heather Francis, et al.. (2007). Prolactin stimulates the proliferation of normal female cholangiocytes by differential regulation of Ca2+-dependent PKC isoforms. BMC Physiology. 7(1). 6–6. 28 indexed citations
7.
Francis, Heather, Antonio Franchitto, Yoshiyuki Ueno, et al.. (2007). H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway. Laboratory Investigation. 87(5). 473–487. 71 indexed citations
8.
DeMorrow, Sharon, Heather Francis, Eugenio Gaudio, et al.. (2007). Anandamide inhibits cholangiocyte hyperplastic proliferation via activation of thioredoxin 1/redox factor 1 and AP-1 activation. American Journal of Physiology-Gastrointestinal and Liver Physiology. 294(2). G506–G519. 44 indexed citations
9.
DeMorrow, Sharon, Shannon Glaser, Heather Francis, et al.. (2007). Opposing Actions of Endocannabinoids on Cholangiocarcinoma Growth. Journal of Biological Chemistry. 282(17). 13098–13113. 84 indexed citations
10.
Fava, Giammarco, Yoshiyuki Ueno, Shannon Glaser, et al.. (2006). Thyroid hormone inhibits biliary growth in bile duct-ligated rats by PLC/IP3/Ca2+-dependent downregulation of SRC/ERK1/2. American Journal of Physiology-Cell Physiology. 292(4). C1467–C1475. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026